Procurement Summary
Country: Brazil
Summary: Intention to Register Prices for Future and Possible Acquisition of Medicines (Transition, Women'S Health and Antimicrobials) - Intention Rp 157/2025 (For all Items, the Descriptions Made Available...
Deadline: 18 Mar 2026
Posting Date: 13 Feb 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 135739471
Document Ref. No.: 90065/2026
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_details
Login to see detailsTender Details
Object: Electronic Auction - Intention to Register Prices for future and possible ACQUISITION OF MEDICINES (TRANSITION, WOMEN'S HEALTH AND ANTIMICROBIALS) - INTENTION RP 157/2025 (FOR ALL ITEMS, THE DESCRIPTIONS AVAILABLE ON COMPRAS NET DIFFER FROM THE TERMS OF REFERENCE, CONSIDER THE TERMS OF REFERENCE OF THIS CERTIFICATE FOR PRESENTATION OF ITEMS, AS PUBLICATION ON THE NOTICE BOARD). UASG code: 925998 Notice from: 02/13/2026 from 08:00 to 14:00 Proposal Delivery: from 02/13/2026 at 08:00 ETONOGESTREL, CONCENTRATION 68 MG, PHARMACEUTICAL FORM SUBDERMAL IMPLANT Quantity: 60 ALBENDAZOLE, 400 MG CONCENTRATION, PHARMACEUTICAL FORM, CHEWABLE TABLET Quantity: 22314 Doxycycline, dosage 100 mg Quantity: 8640 LEVOFLOXACIN, CONCENTRATION 750 MG Quantity: 9660 MICONAZOLE NITRATE, DOSAGE 2%, VAGINAL CREAM PRESENTATION Quantity: 3000 ESTRADIOL, COMPOSITION 17-BETA ESTRADIOL, CONCENTRATION 0.6 MG/G, PHARMACEUTICAL GEL FORM, ADDITIONAL CHARACTERISTICS WITH DOSING RULE Quantity: 4608 ESTRADIOL, COMPOSITION 17-BETA ESTRADIOL, CONCENTRATION 0.6 MG/G, PHARMACEUTICAL GEL FORM, ADDITIONAL CHARACTERISTICS WITH DOSING RULE Quantity: 1536 TESTOSTERONE, COMPOSITION CYPIONATE SALT, CONCENTRATION 100 MG/ML, PHARMACEUTICAL FORM SOLUTION INJECTABLE Quantity: 2457 TESTOSTERONE, COMPOSITION CYPIONATE SALT, CONCENTRATION 100 MG/ML, PHARMACEUTICAL FORM INJECTABLE SOLUTION Quantity: 819 TESTOSTERONE, UNDECYLATE SALT COMPOSITION, CONCENTRATION 250 MG/ML, PHARMACEUTICAL FORM INJECTABLE SOLUTION Quantity: 3078 TESTOSTERONE, UNDECYLATE SALT COMPOSITION, CONCENTRATION 250 MG/ML, PHARMACEUTICAL FORM INJECTABLE SOLUTION Quantity: 198 LEVONORGESTREL, CONCENTRATION 52 MG, ADDITIONAL CHARACTERISTICS INTRA-UTERINE SYSTEM, WITH INSERTER Quantity: 1370 LEVONORGESTREL, CONCENTRATION 52 MG, ADDITIONAL CHARACTERISTICS INTRA-UTERINE SYSTEM, WITH INSERTER Wh...
Documents
Tender Notice